Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1107-2020Class II

VIDAS Varicella Zoster IgG (VZG) antibody IVD, kit

bioMerieux, Inc. / initiated 2019-12-10 / Terminated / root cause: manufacturing process

bioMerieux, Inc. began a recall of VIDAS Varicella Zoster IgG (VZG) antibody IVD, kit on . FDA classified it as Class II and gives the reason as "Two batches of VIDAS Varicella-Zoster IgG (VZG ref 30217) may yield an invalid calibration which may delay the patient's sample result or a valid calibration may lead to a false positive patient result". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1107-2020
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
bioMerieux, Inc.
Product
VIDAS Varicella Zoster IgG (VZG) antibody IVD, kit
Product code
LFY Enzyme Linked Immunoabsorbent Assay, Varicella-Zoster
Reason for recall
Two batches of VIDAS Varicella-Zoster IgG (VZG ref 30217) may yield an invalid calibration which may delay the patient's sample result or a valid calibration may lead to a false positive patient result.
Root cause tag
manufacturing process
FDA root cause
Unknown/Undetermined by firm
Action
Users are instructed via customer letter to stop using the VIDAS VZG batches 1007410330 and 1007393380 and destroy the remaining products.
Quantity in commerce
1,218 US units total (726 US, 492 OUS)
Distribution
Distributed nationwide and 9 units to Biomerieux Canada.
Product codes and lots
US Model 30217-01 Lot 1007410330 and 1007393380

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1107-2020
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1107-2020Class IITerminatedVoluntary: Firm initiated